As of 2024-12-13, the Fair Value of Genomic Vision SA (GV.PA) is -0.14 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 EUR, the upside of Genomic Vision SA is -7,746.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -6.90 | -4.61 | -5.18 | -5.00 | -6.79 | -5.69 |
| YoY growth | 23.96% | 33.20% | -12.35% | 3.46% | -35.85% | 2.48% |
| Market Cap (mil) | 0.69 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | 2.48% |
| TTM earnings | -10.62 |